Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.

Herman, J F

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. [electronic resource] - Oncogene May 2006 - 3049-58 p. digital

Publication Type: Comparative Study; Journal Article

0950-9232

10.1038/sj.onc.1209324 doi


ATP Binding Cassette Transporter, Subfamily B, Member 1--deficiency
Adenocarcinoma--enzymology
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Breast Neoplasms--enzymology
Cell Adhesion--drug effects
Cell Line, Tumor--drug effects
Culture Media, Serum-Free--pharmacology
Doxorubicin--pharmacology
Drug Resistance, Neoplasm--genetics
Enzyme Induction
Female
Fibronectins--metabolism
Focal Adhesion Kinase 1--physiology
GTP-Binding Proteins
Humans
Integrin alpha4--metabolism
Integrin alpha5--metabolism
Integrin beta Chains--metabolism
Integrin beta1--metabolism
Neoplasm Proteins--antagonists & inhibitors
Protein Glutamine gamma Glutamyltransferase 2
RNA, Small Interfering--pharmacology
Transglutaminases--antagonists & inhibitors